0001975776-23-000001.txt : 20230504 0001975776-23-000001.hdr.sgml : 20230504 20230504172140 ACCESSION NUMBER: 0001975776-23-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20230504 DATE AS OF CHANGE: 20230504 EFFECTIVENESS DATE: 20230504 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Ancilia Biosciences, Inc. CENTRAL INDEX KEY: 0001975776 IRS NUMBER: 834260764 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-480881 FILM NUMBER: 23890154 BUSINESS ADDRESS: STREET 1: 3960 BROADWAY, 6TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10032 BUSINESS PHONE: (929) 578-0778 MAIL ADDRESS: STREET 1: 3960 BROADWAY, 6TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10032 D 1 primary_doc.xml X0708 D LIVE 0001975776 Ancilia Biosciences, Inc. 3960 BROADWAY, 6TH FLOOR NEW YORK NY NEW YORK 10032 (929) 578-0778 DELAWARE None None Corporation true 2019 Alexandra Sakatos 3960 Broadway, 6th Floor New York NY NEW YORK 10032 Executive Officer Director Rodolphe Barrangou 3960 Broadway, 6th Floor New York NY NEW YORK 10032 Executive Officer Director Dale Pfost 3960 Broadway, 6th Floor New York NY NEW YORK 10032 Director Biotechnology Decline to Disclose 06b false 2023-04-13 false true false 0 5000000 1000000 4000000 false 2 0 0 0 false Ancilia Biosciences, Inc. /s/ Sean D. Valle Sean D. Valle Attorney-In-Fact 2023-05-04